Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.25 USD | -0.29% | +0.99% | -29.60% |
Financials (USD)
Sales 2022 | 25.9M | Sales 2023 | 42.81M | Capitalization | 17.99M |
---|---|---|---|---|---|
Net income 2022 | -33M | Net income 2023 | -24M | EV / Sales 2022 | 1.21 x |
Net cash position 2022 | 46.07M | Net cash position 2023 | 26.37M | EV / Sales 2023 | -0.2 x |
P/E ratio 2022 |
-2.32
x | P/E ratio 2023 |
-0.67
x | Employees | 48 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.03% |
Latest transcript on Pieris Pharmaceuticals, Inc.
1 day | -0.29% | ||
1 week | +0.99% | ||
Current month | +0.99% | ||
1 month | -7.16% | ||
3 months | -27.98% | ||
6 months | -33.41% | ||
Current year | -29.60% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Yoder
CEO | Chief Executive Officer | 48 | 09-12-31 |
Thomas Bures
DFI | Director of Finance/CFO | 49 | 17-11-30 |
Kayti Aviano
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 16-09-19 | |
James Geraghty
CHM | Chairman | 69 | 17-05-21 |
Michael Richman
BRD | Director/Board Member | 63 | 14-12-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 10.25 | -0.29% | 4,130 |
24-06-06 | 10.28 | -0.10% | 5,761 |
24-06-05 | 10.29 | -0.07% | 3,095 |
24-06-04 | 10.3 | +0.96% | 5,138 |
24-06-03 | 10.2 | +0.49% | 4,343 |
Delayed Quote Nasdaq, June 07, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-29.60% | 13.53M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- PIRS Stock